1. Home
  2. DPRO vs ENTX Comparison

DPRO vs ENTX Comparison

Compare DPRO & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • ENTX
  • Stock Information
  • Founded
  • DPRO 1998
  • ENTX 2010
  • Country
  • DPRO Canada
  • ENTX Israel
  • Employees
  • DPRO N/A
  • ENTX N/A
  • Industry
  • DPRO Aerospace
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DPRO Industrials
  • ENTX Health Care
  • Exchange
  • DPRO Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • DPRO 169.4M
  • ENTX 142.0M
  • IPO Year
  • DPRO N/A
  • ENTX 2018
  • Fundamental
  • Price
  • DPRO $7.37
  • ENTX $2.40
  • Analyst Decision
  • DPRO Strong Buy
  • ENTX Strong Buy
  • Analyst Count
  • DPRO 3
  • ENTX 1
  • Target Price
  • DPRO $15.67
  • ENTX $10.00
  • AVG Volume (30 Days)
  • DPRO 2.5M
  • ENTX 122.1K
  • Earning Date
  • DPRO 11-12-2025
  • ENTX 11-14-2025
  • Dividend Yield
  • DPRO N/A
  • ENTX N/A
  • EPS Growth
  • DPRO N/A
  • ENTX N/A
  • EPS
  • DPRO N/A
  • ENTX N/A
  • Revenue
  • DPRO $5,335,758.00
  • ENTX $124,000.00
  • Revenue This Year
  • DPRO $39.47
  • ENTX N/A
  • Revenue Next Year
  • DPRO $155.03
  • ENTX N/A
  • P/E Ratio
  • DPRO N/A
  • ENTX N/A
  • Revenue Growth
  • DPRO 26.74
  • ENTX 25.25
  • 52 Week Low
  • DPRO $1.63
  • ENTX $1.50
  • 52 Week High
  • DPRO $14.40
  • ENTX $3.22
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 45.81
  • ENTX 41.26
  • Support Level
  • DPRO $6.42
  • ENTX $2.26
  • Resistance Level
  • DPRO $7.70
  • ENTX $2.73
  • Average True Range (ATR)
  • DPRO 0.87
  • ENTX 0.23
  • MACD
  • DPRO -0.02
  • ENTX -0.08
  • Stochastic Oscillator
  • DPRO 44.43
  • ENTX 13.48

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: